DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Yardley DA, Coleman R, Conte P. et al.
nab-Paclitaxel plus carboplatin or gemcitabine versus gemcitabine plus carboplatin as first-line treatment of patients with triple-negative metastatic breast cancer: results from the tnAcity trial.
Ann Oncol 2018;
29: 1763-1770
We do not assume any responsibility for the contents of the web pages of other providers.